share_log

Dawson James Initiates Coverage On Zomedica With Buy Rating, Announces Price Target of $6

Benzinga Real-time News ·  Jan 6, 2023 08:27

Dawson James analyst Jason Kolbert initiates coverage on Zomedica (AMEX:ZOM) with a Buy rating and announces Price Target of $6.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment